Teva intros generic Jadenu in new dosage strengths

Teva is debuting deferasirox tablets in a dosage strength of 180 mg.  It is the generic of Novartis’ Jadenu (deferasirox) tablets.

The 180 mg strength joins the 90 mg and 360 mg strengths in Teva’s line.

All strengths of Teva’s Jadenu are available in bottle sizes of 30 tablets.

The product is used for chronic iron overload due to blood transfusions.